Bill Ackman isn’t known for always being right, Intelligencer writes. He is, however, known for influencing large numbers of other investors, selling them on his ideas, and sometimes making them lots and lots of money — but also sometimes being disastrously wrong, failing to deliver on his promises, and losing lots of everyone’s money in the process. Early last year, Ackman made billions of dollars betting the markets would fall as COVID spread around the globe. A few years prior to that, he lost a fortune on a high-profile bet that he could get supplements-maker Herbalife declared a pyramid scheme by regulators (who declined to do so). Read more.
Related Posts
New SPAC Sees Growing Market Opportunities for Stakeholder-Minded Businesses And Investors: Report
One new SPAC is organized as a public benefit corporation and a Pending B Corporation, and it plans to invest in companies that both address the United Nations’ Sustainable Development Goals and that are capable of becoming Certified B Corporations, Forbes reports.
Cerevel Therapeutics Debuts on Nasdaq
Cerevel Therapeutics begins trading on the Nasdaq today following merger with Arya Sciences Acquisition Corp II.
SPAC Lawsuits Double as Other Shareholder Class Actions Plunge: Report
Federal suits against SPACs have continued to pile up, with 14 such filings in the first half of 2021, compared to seven in all of 2020 and six in 2019.
SPACs are Here to Stay, Raymond James Banker Says
Jim Bunn, head of global equities and investment banking at Raymond James Financial, discusses the outlook for SPACs and M&A activity in this interview with CNBC.